![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 19, 2022 12:34:36 PM
7/17/22, 05:27 PM
As a clinical trials physician I can attest to the reality that undertaking any clinical trials venue is extremely expensive, AND extraordinarily demanding and time consuming. It requires a Multi-Million Dollar CASH Bank Roll of not less than $150 Million (low end) that can be drawn from on demand, AND an army of qualified advanced degree professionals across dozen's of levels, daily for months on end, typically years. The ONLY venues that fits this description are a Contract Research Organization (CRO) or a Big Pharma. There would be no possible way for Koos to "go it alone." Everyone also needs to understand that Oncology Pharma is NOT a CRO. They are an Intellectual Property Broker that acquires candidate drug IP development rights typically from Biopharmas like RGBP, then turns around and outsources it to a CRO for conducting clinical trials. They also resource capital to fund clinical trials they initiate to a CRO. CROs typically don't fund clinical trials.
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM